Moderna Inc (NAS:MRNA)
$ 133.4 0.72 (0.54%) Market Cap: 51.12 Bil Enterprise Value: 43.69 Bil PE Ratio: 0 PB Ratio: 3.98 GF Score: 68/100

Q4 2019 Moderna Inc Earnings Call Transcript

Feb 26, 2020 / 01:00PM GMT
Release Date Price: $29.16 (+22.73%)
Operator

Good morning. And welcome to Moderna's Fourth Quarter and Full Year 2019 Conference Call. (Operator Instructions) Please be advised that the call is being recorded. At this time, I'd like to turn the call over to Lavina Talukdar, Head, Investor Relations at Moderna. Please proceed.

Lavina Talukdar
Moderna, Inc. - Head of IR

Thank you, operator. Good morning, everyone. On today's call, we will discuss Moderna's fourth quarter and full year 2019 business update and financial results. You can access the press release issued this morning as well as the slides that we'll be reviewing by going to the Investors section of our website. Speaking on today's call are Stéphane Bancel, our Chief Executive Officer; Tal Zaks, our Chief Medical Officer; Stephen Hoge, our President; and Lorence Kim, our Chief Financial Officer.

Before we begin, I would like to remind everyone that this conference call will include forward-looking statements. Please see Slide 2 of the accompanying presentation and our SEC filings for important risk factors that could cause our actual

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot